precision oncology

Oncology

Establishing ctDNA as a validated primary surrogate endpoint

Circulating tumour DNA (ctDNA) has emerged as a promising primary surrogate endpoint in solid tumour oncology.

Oncology

Bridging the cancer drug development gap: AI-driven precisio...

Functional precision oncology gives physicians the data they need to make better decisions about each patient’s care.

Oncology

From promise to practice: What must happen next for genetic ...

The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.

Digital

The role of AI technologies in precision oncology

By focusing on assistance to the front-line oncologist, AI can enable improved diagnosis, clinical trials, and timely, accurate decision making.

News

Now Iktos teams up with Pierre Fabre in oncology

As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos

Oncology

Why functional cancer profiling has the potential to transfo...

Functional cancer profiling is an important step forward in the progress of oncology treatment, with the potential to transform patient outcomes.

Establishing ctDNA as a validated primary surrogate endpoint

Bridging the cancer drug development gap: AI-driven precisio...

From promise to practice: What must happen next for genetic ...

The role of AI technologies in precision oncology

Now Iktos teams up with Pierre Fabre in oncology

Why functional cancer profiling has the potential to transfo...

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

precision oncology

Editor's Picks